RESILIENCE GOVERNMENT SERVICES, INC.
ALACHUA, Florida
Total Received
$409.1M
Total Awards
7
State
Florida
Last Updated
Dec 31, 2025
Yearly Funding Trend
$409.1M24
Top 7 Awards to RESILIENCE GOVERNMENT SERVICES, INC.
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through December 31, 2025.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_W911QY13C0010_9700_-NONE-_-NONE- THIS CONTRACT WILL PROVIDE THE DEPARTMENT OF DEFENSE WITH THE ADVANCED DEVELOPMENT AND MANUFACTURING CAPABILITY TO RAPIDLY DEVELOP, APPROVE AND MANUFACTURE MEDICAL COUNTERMEASURES. | Department of Defense Department of the Army | — | ALACHUA, FL-03 | 2024 | $276,824,216 |
CONT_AWD_W911SR22F0014_9700_W911SR22D0009_9700 THIS DELIVERY ORDER IS FOR TASKS ASSOCIATED WITH THE DEVELOPMENT OF US FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE. | Department of Defense Department of the Army | — | FREDERICK, MD-06 | 2024 | $107,935,343 |
CONT_AWD_75N93019C00057_7529_-NONE-_-NONE- PRODUCTION OF A MAB-BASED THERAPEUTIC DIRECTED AGAINST A BROAD SPECTRUM OF HIGHLY DIVERSE BOTULINUM NEUROTOXIN SEROTYPE F SUBTYPES AND DISCOVERY WORK OF MAB AGAINST BOTULINUM NEUR… | Department of Health and Human Services National Institutes of Health | — | ALACHUA, FL-03 | 2024 | $15,120,173 |
CONT_AWD_W911SR22F0073_9700_W911SR22D0009_9700 THIS DELIVERY ORDER IS FOR RESEARCH AND DEVELOPMENT TASKS ASSOCIATED WITH DEVELOPING A US FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NE… | Department of Defense Department of the Army | — | ALACHUA, FL-03 | 2024 | $4,459,366 |
CONT_AWD_W911SR23F0057_9700_W911SR22D0009_9700 THIS DELIVERY ORDER IS FOR TASKS ASSOCIATED WITH THE DEVELOPMENT OF US FOOD AND DRUG ADMINISTRATION LICENSED MONOCLONAL ANTIBODY COUNTERMEASURE FOR BOTULINUM NEUROTOXIN EXPOSURE. | Department of Defense Department of the Army | — | ALACHUA, FL-03 | 2024 | $4,278,565 |
CONT_AWD_75N93023F00001_7529_HHSN272201600006I_7529 DEVELOPMENT OF LNA14 ANALYTICAL METHODS AND UPSTREAM AND DOWNSTREAM PROCESSES FOR MANUFACTURING, AND SCALE-UP MANUFACTURING AND RELEASE TESTING OF THE PURIFIED LNA14 PRODUCT | Department of Health and Human Services National Institutes of Health | — | ALACHUA, FL-03 | 2024 | $485,288 |
CONT_IDV_W911SR22D0009_9700 THIS CONTRACT WILL COMPLETE ADVANCED DEVELOPMENT OF THE MONOCLONAL ANTIBODY DRUG PRODUCT, G03-52-01, TO REGULATORY APPROVAL FOR PROPHYLAXIS (POST-EXPOSURE AND/OR PRE-EXPOSURE) TO… | Department of Defense Department of the Army | — | — | 2024 | $0 |
Top 7 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→Source: USAspending.gov · All Recipients · Florida